Role of Cytomegalovirus Reinfection in Acute Rejection and CMV Disease After Renal Transplantation

QR Code

Role of Cytomegalovirus Reinfection in Acute Rejection and CMV Disease After Renal Transplantation

None

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Ishibashi, Kei, Suzutani, Tatsuo
Hōputu:	Tāhiko Wāhanga pukapuka
Reo:	Ingarihi
I whakaputaina:	IntechOpen 2012
Ngā marau:	Health Sciences
Urunga tuihono:	https://www.intechopen.com/chapters/29967
Tags:	Tāpirihia he Tūtohu No Tags, Be the first to tag this record!

Ngā tūemi rite

CMV Infection in CMV-Seropositive Kidney Transplant Recipients
mā: Kim, Jong Man, me ētahi atu.
I whakaputaina: (2011)

CMV-infection in patients after liver transplantation
mā: M. Sh. Khubutiya, me ētahi atu.
I whakaputaina: (2016-02-01)

Early acute rejection after liver transplantation
mā: N. V. Shmarina, me ētahi atu.
I whakaputaina: (2018-08-01)

Acute Renal Failure Induced by Adenovirus After Stem Cell Transplantation
mā: Abe, Takashi, me ētahi atu.
I whakaputaina: (2011)

THE VALUE OF EXTRACORPOREAL PHOTOCHEMOTHERAPY IN RENAL TRANSPLANT REJECTION INHIBITION
mā: V. A. Fedulkina, me ētahi atu.
I whakaputaina: (2016-06-01)

Effector-Memory γδ T Lymphocytes Predict CMV Disease After the Withdrawal of Prophylaxis in Kidney Transplant Recipients
mā: Yoann Abadie, me ētahi atu.
I whakaputaina: (2025-07-01)

CCR2 and TLR3: noninvasive macrophage-associated biomarkers of acute renal transplant rejection
mā: Shili Wang, me ētahi atu.
I whakaputaina: (2025-12-01)

The incidence and risk factors of chronic rejection in acutely rejected pediatric liver transplantation
mā: S. M. Dehghani, me ētahi atu.
I whakaputaina: (2022-01-01)

PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS
mā: V. V. Ryazhenov, me ētahi atu.
I whakaputaina: (2011-06-01)

Soluble CD30 and Acute Renal Allograft Rejection
mā: Kamali, Koosha, me ētahi atu.
I whakaputaina: (2012)

Risk factors of CMV replication after allogeneic hematopoietic stem cell transplantation in children and adolescents
mā: S. N. Shiriaev, me ētahi atu.
I whakaputaina: (2014-09-01)

Risk factors affecting the incidence of CMV infection in recipients after living donor liver transplantation
mā: Mostafa Attya Elfors, me ētahi atu.
I whakaputaina: (2025-06-01)

Detection of cytomegalovirus (CMV) in fecal samples of cholestasis infants by real-time Polymerase-Chain Reaction - A pilot study
mā: Nur Azizah, me ētahi atu.
I whakaputaina: (2025-08-01)

FEATURES OF CLINICAL DISPLAYS OF THE TRANSPLANTED HEART ACUTE REJECTION
mā: S. J. Shemakin, me ētahi atu.
I whakaputaina: (2010-06-01)

THE RELATIONSHIP OF QUILTY EFFECT TO ACUTE REJECTION OF THE TRANSPLANTED HEART
mā: I. M. Iljinsky, me ētahi atu.
I whakaputaina: (2016-01-01)

CURRENT VIEW ON MORPHOLOGY OF ACUTE REJECTION IN LIVER TRANSPLANTATION
mā: L.V. Shkalova, me ētahi atu.
I whakaputaina: (2012-03-01)

A porcine model of acute rejection for cardiac transplantation
mā: Michelle Mendiola Pla, me ētahi atu.
I whakaputaina: (2025-07-01)

The impact of early acute rejection on kidney graft survival after repeat kidney transplantation
mā: A. V. Pinchuk, me ētahi atu.
I whakaputaina: (2021-09-01)

CHALLENGES IN TREATMENT OF RENAL GRAFT ACUTE ANTIBODY-MEDIATED REJECTION
mā: A. I. Sushkov, me ētahi atu.
I whakaputaina: (2016-06-01)

VITAL COMPUTER MORPHOMETRY OF LIMPHOCYTES IN DIAGNOSIS OF ACUTE RENAL ALLOGRAFT REJECTION
mā: A. V. Vatazin, me ētahi atu.
I whakaputaina: (2009-06-01)

The Recurrence of Infection: Recrudescence Versus Reinfection
mā: Jong Kyu Park
I whakaputaina: (2023-12-01)

Cytomegalovirus infection in patients after orthotopic liver transplantation (clinical report)
mā: D. O. Efremov, me ētahi atu.
I whakaputaina: (2019-12-01)

FEATURES OF PLASMAPHERESIS IN THE TREATMENT OF GRAFT REJECTION AFTER KIDNEY TRANSPLANTATION
mā: A. V. Vatazin, me ētahi atu.
I whakaputaina: (2015-10-01)

INTRAVENOUS IMMUNOGLOBULIN ADMINISTRATION FOR DESENSITIZATION BEFORE RENAL TRANSPLANTATION AND MANAGING ANTIBODY-MEDIATED REJECTION
mā: A. I. Sushkov, me ētahi atu.
I whakaputaina: (2011-06-01)

CONVERSION TO TACROLIMUS IN PATIENTS WITH LATE ACUTE AND CHRONIC REJECTION OF TRANSPLANTED KIDNEY
mā: E. S. Stolyarevich, me ētahi atu.
I whakaputaina: (2011-06-01)

Transient Azoospermia Induced by Valganciclovir Treatment for Cytomegalovirus Infection in a Reproductive Male After Kidney Transplant: A Case Report
mā: Kosuke Mieda, me ētahi atu.
I whakaputaina: (2025-07-01)

Chest Pain in a Renal Transplant Recipient due to Concomitant Cytomegalovirus and Herpes Simplex Virus Esophagitis
mā: Seok Hyung Kang, me ētahi atu.
I whakaputaina: (2019-03-01)

An impact of CMV and HHV-6 reactivation on the course of early period after hematopoietic stem cell transplantation in patients with hematologic malignancies
mā: T. V. Antonova, me ētahi atu.
I whakaputaina: (2023-01-01)

ST2 IN REJECTION OF THE TRANSPLANTED HEART
mā: O. P. Shevchenko, me ētahi atu.
I whakaputaina: (2016-01-01)

Antibody-mediated rejection in heart transplantation
mā: V. S. Kvan, me ētahi atu.
I whakaputaina: (2022-01-01)

LATE RENAL GRAFT REJECTION: PATHOLOGY AND PROGNOSIS
mā: E.S. Stolyarevich, me ētahi atu.
I whakaputaina: (2014-05-01)

PRO – AND ANTI-INFLAMMATORY CYTOKINES ARE EARLY MARKERS OF ACUTE REJECTION OF THE TRANSPLANTED KIDNEY
mā: T. V. FEDORENKO, me ētahi atu.
I whakaputaina: (2018-07-01)

Risk factors of cytomegalovirus infection in patients after allogeneic hematopoietic stem cells transplantation
mā: D. N. Balashov, me ētahi atu.
I whakaputaina: (2022-11-01)

Cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: clinical significance and definitions
mā: A. A. Dmitrova, me ētahi atu.
I whakaputaina: (2022-06-01)

Cytomegalovirus mismatch after heart transplantation: Impact of antiviral prophylaxis and intravenous hyperimmune globulin
mā: Moritz B. Immohr, me ētahi atu.
I whakaputaina: (2021-12-01)

Herd immunity and prevention in HPV transmission with exogenous reinfection.
mā: Md Mehedi Hasan, me ētahi atu.
I whakaputaina: (2025-01-01)

Soil-transmitted helminth reinfection after drug treatment: a systematic review and meta-analysis.
mā: Tie-Wu Jia, me ētahi atu.
I whakaputaina: (2012-01-01)

Galectin-3 in heart transplant rejection and fibrosis
mā: O. P. Shevchenko, me ētahi atu.
I whakaputaina: (2019-10-01)

DYNAMICS OF IRIG IN TREATMENT OF HEART TRANSPLANT REJECTIONS
mā: A. O. Shevchenko, me ētahi atu.
I whakaputaina: (2015-10-01)

THE ROLE OF SPECKLE-TRACKING ECHOCARDIOGRAPHY TECHNIQUE AT THE STAGE OF SUBCLINICAL HEART TRANSPLANT REJECTION
mā: T. V. Stavenchuk, me ētahi atu.
I whakaputaina: (2016-01-01)